SCHEMBL16904662

SCHEMBL16904662

COC(=O)Cc1cc(C(=O)c2ccc(Br)cc2)sc1-c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.56
MEN1 O00255 5/20 0.56
KMT2A Q03164 5/20 0.56
ALDH1A1 P00352 3/20 0.56
HTT P42858 2/20 0.56
TP53 P04637 3/20 0.49
RXFP1 Q9HBX9 3/20 0.47
RAB9A P51151 4/20 0.39
HPGD P15428 4/20 0.39
NPC1 O15118 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
PKM P14618 1/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
NPSR1 Q6W5P4 2/20 0.38
ERO1A Q96HE7 1/20 0.37
KDM4E B2RXH2 3/20 0.37
LMNA P02545 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16893413 0.92 MAPT (0.46) MAPTMEN1KMT2AALDH1A1HTT
SCHEMBL16893534 0.88 MEN1 (0.53) MAPTMEN1KMT2AALDH1A1HTT
SCHEMBL3053459 0.88 MEN1 (0.50) MAPTMEN1KMT2AALDH1A1HTT
SCHEMBL16904651 0.87 MAPT (0.68) MAPTMEN1KMT2AALDH1A1HTT
SCHEMBL3057661 0.86 KMT2A (0.58) MAPTMEN1KMT2AALDH1A1HTT
SCHEMBL3058700 0.84 MAPT (0.56) MAPTMEN1KMT2AALDH1A1HTT
SCHEMBL16893377 0.82 MEN1 (0.48) MAPTMEN1KMT2AALDH1A1HTT
SCHEMBL16893438 0.82 MAPK13 (0.49) MAPTMEN1KMT2AHTTRXFP1
SCHEMBL14645336 0.81 NPSR1 (0.43) MAPTMEN1KMT2AALDH1A1HTT
SCHEMBL7030018 0.79 MAPT (0.46) MAPTMEN1KMT2AALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9777015-B2 Useful thiophene derivatives in the treatment of diabetes METABRAIN RESEARCH (FR) 2017-10-03 US disclosed
US-9777015-B2 Useful thiophene derivatives in the treatment of diabetes METABRAIN RESEARCH (FR) 2017-10-03 US disclosed
EP-2875010-B1 THIOPHENE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES METABRAIN RES (FR) 2016-08-31 EP disclosed
US-20150197530-A1 USEFUL THIOPHENE DERIVATIVES IN THE TREATMENT OF DIABETES METABRAIN RESEARCH (FR) 2015-07-16 US disclosed
US-20150197530-A1 USEFUL THIOPHENE DERIVATIVES IN THE TREATMENT OF DIABETES METABRAIN RESEARCH (FR) 2015-07-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150197530-A1 USEFUL THIOPHENE DERIVATIVES IN THE TREATMENT OF DIABETES SLC5A2, SLC5A1, TPMT MAPT 46/4885MEN1 4184/4885KMT2A 4602/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.